Sebastian Palmqvist, MD, PhD
Sebastian Palmqvist, MD, PhD
Associate professor at Lund University, Consultant Neurologist at Skåne University Hospital (Sweden)
Verified email at - Homepage
Cited by
Cited by
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ...
Nature medicine 26 (3), 379-386, 2020
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...
The Lancet Neurology 19 (5), 422-433, 2020
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...
Nature communications 8 (1), 1214, 2017
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...
Jama 324 (8), 772-781, 2020
Plasma β-amyloid in Alzheimer’s disease and vascular disease
S Janelidze, E Stomrud, S Palmqvist, H Zetterberg, D Van Westen, ...
Scientific reports 6 (1), 26801, 2016
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
S Janelidze, H Zetterberg, N Mattsson, S Palmqvist, H Vanderstichele, ...
Annals of clinical and translational neurology 3 (3), 154-165, 2016
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography
S Palmqvist, H Zetterberg, K Blennow, S Vestberg, U Andreasson, ...
JAMA neurology 71 (10), 1282-1289, 2014
Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder
O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ...
Neurology 88 (10), 930-937, 2017
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
S Palmqvist, N Mattsson, O Hansson, ADN Initiative
Brain 139 (4), 1226-36, 2016
Discriminative accuracy of [18F] flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ...
Jama 320 (11), 1151-1162, 2018
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, L Minthon, ...
Neurology 85 (14), 1240-1249, 2015
Performance of fully automated plasma assays as screening tests for Alzheimer disease–related β-amyloid status
S Palmqvist, S Janelidze, E Stomrud, H Zetterberg, J Karl, K Zink, T Bittner, ...
JAMA neurology 76 (9), 1060-1069, 2019
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
S Janelidze, E Stomrud, R Smith, S Palmqvist, N Mattsson, DC Airey, ...
Nature communications 11 (1), 1683, 2020
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
N Mattsson, PS Insel, S Palmqvist, E Portelius, H Zetterberg, M Weiner, ...
EMBO molecular medicine 8 (10), 1184-1196, 2016
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
S Palmqvist, PS Insel, E Stomrud, S Janelidze, H Zetterberg, B Brix, ...
EMBO molecular medicine 11 (12), e11170, 2019
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
S Janelidze, N Mattsson, E Stomrud, O Lindberg, S Palmqvist, ...
Neurology 91 (9), e867-e877, 2018
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
R Ossenkoppele, R Smith, T Ohlsson, O Strandberg, N Mattsson, PS Insel, ...
Neurology 92 (6), e601-e612, 2019
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
S Palmqvist, P Tideman, N Cullen, H Zetterberg, K Blennow, ...
Nature medicine 27 (6), 1034-1042, 2021
18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
N Mattsson, M Schöll, O Strandberg, R Smith, S Palmqvist, PS Insel, ...
EMBO molecular medicine 9 (9), 1212-1223, 2017
The system can't perform the operation now. Try again later.
Articles 1–20